Micelle-like nanoparticles as siRNA and miRNA carriers for cancer therapy

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Biomedical microdevices

• Publication date

  2018-07-12

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1007/s10544-018-0298-0PMID 29998417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis, characterization, and in vitro cytotoxicity of fatty acyl-CGKRK-chitosan oligosaccharides conjugates for siRNA delivery.

  2018cited by this paper
• Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.

  2018cited by this paper
• RNA interference-based therapy and its delivery systems

  2018cited by this paper
• Alnylam prepares to land first RNAi drug approval

  2018cited by this paper
• Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer

  2018cited by this paper
• Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate.

  2017cited by this paper
• Polymer nanoassemblies with hydrophobic pendant groups in the core induce false positive siRNA transfection in luciferase reporter assays.

  2017cited by this paper
• Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy

  2017cited by this paper
• The expression of miRNAs is associated with tumour genome instability and predicts the outcome of ovarian cancer patients treated with platinum agents

  2017cited by this paper
• Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics

  2017cited by this paper
• Self-Assembly of Amphiphilic Dendrimers: The Role of Generation and Alkyl Chain Length in siRNA Interaction

  2016cited by this paper
• Mixed Nanosized Polymeric Micelles as Promoter of Doxorubicin and miRNA-34a Co-Delivery Triggered by Dual Stimuli in Tumor Tissue.

  2016cited by this paper
• Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy

  2016cited by this paper
• miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R

  2016cited by this paper
• Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation.

  2015cited by this paper
• Non-Specific Blocking of miR-17-5p Guide Strand in Triple Negative Breast Cancer Cells by Amplifying Passenger Strand Activity

  2015cited by this paper
• Physicochemical perspectives (aggregation, structure and dynamics) of interaction between pluronic (L31) and surfactant (SDS).

  2015cited by this paper
• MicroRNA-519a promotes proliferation and inhibits apoptosis of hepatocellular carcinoma cells by targeting FOXF2

  2015cited by this paper
• Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation

  2015cited by this paper
• Technologies for controlled, local delivery of siRNA.

  2015cited by this paper
• MicroRNA-212 functions as an epigenetic-silenced tumor suppressor involving in tumor metastasis and invasion of gastric cancer through down-regulating PXN expression.

  2015cited by this paper
• siRNA Delivery by Stimuli-Sensitive Nanocarriers.

  2015cited by this paper
• Polycation‐mediated gene delivery: Challenges and considerations for the process of plasmid DNA transfection

  2015cited by this paper
• miRNAs in pancreatic cancer: therapeutic potential, delivery challenges and strategies.

  2015cited by this paper
• microRNA-32 induces radioresistance by targeting DAB2IP and regulating autophagy in prostate cancer cells

  2015cited by this paper
• Multifunctional Polymeric Micelles Co-loaded with Anti–Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer

  2015cited by this paper
• Global miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal Carcinoma

  2015cited by this paper
• Systemic in vivo delivery of siRNA to tumours using combination of polyethyleneimine and transferrin-polyethyleneimine conjugates.

  2015cited by this paper
• Smart functional nucleic acid chimeras: Enabling tissue specific RNA targeting therapy

  2015cited by this paper
• Strand-specific in vivo screen of cancer-associated miRNAs unveils a role for miR-21∗ in SCC progression

  2015cited by this paper
• Recent Advances in Dendrimer Research for Cardiovascular Diseases.

  2015cited by this paper
• Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic Acid

  2015cited by this paper
• Micelle-like nanoparticles as carriers for DNA and siRNA.

  2015cited by this paper
• Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide

  2014cited by this paper
• Target-responsive DNA/RNA nanomaterials for microRNA sensing and inhibition: the jack-of-all-trades in cancer nanotheranostics?

  2014cited by this paper
• Therapeutic targeting of microRNAs: current status and future challenges

  2014cited by this paper
• Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA

  2014cited by this paper
• Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs.

  2014cited by this paper
• Phospholipid-modified polyethylenimine-based nanopreparations for siRNA-mediated gene silencing: implications for transfection and the role of lipid components.

  2014cited by this paper
• Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancer.

  2014cited by this paper
• Delivery and Targeting of miRNAs for Treating Liver Fibrosis

  2014cited by this paper
• Hypoxia-targeted siRNA delivery.

  2014cited by this paper
• Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.

  2014cited by this paper
• Nano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistant cancers.

  2014cited by this paper
• Peptides Used in the Delivery of Small Noncoding RNA

  2014cited by this paper
• Multivalent Polymers for Drug Delivery and Imaging: The Challenges of Conjugation

  2014cited by this paper
• Gene therapy clinical trials worldwide to 2012 – an update

  2013cited by this paper
• Progress in microRNA delivery.

  2013cited by this paper
• The possible "proton sponge " effect of polyethylenimine (PEI) does not include change in lysosomal pH.

  2013cited by this paper
• Hydrophobic modification of low molecular weight polyethylenimine for improved gene transfection.

  2013cited by this paper
• MicroRNA-34a Inhibits Human Osteosarcoma Proliferation by Downregulating Ether à go-go 1 Expression

  2013cited by this paper
• Dual ligands modified double targeted nano-system for liver targeted gene delivery

  2013cited by this paper
• BSA Nanoparticles for siRNA Delivery: Coating Effects on Nanoparticle Properties, Plasma Protein Adsorption, and In Vitro siRNA Delivery

  2012cited by this paper
• The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

  2012cited by this paper
• Structure and stability of the complex formed by oligonucleotides.

  2012cited by this paper
• Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.

  2012cited by this paper
• miR221/222 in cancer: their role in tumor progression and response to therapy.

  2012cited by this paper
• Glutathione levels in human tumors

  2012cited by this paper
• Effect of acyl chain length and unsaturation on physicochemical properties and transfection efficiency of N-acyl-substituted low-molecular-weight chitosan.

  2012cited by this paper
• N-hexanoyl, N-octanoyl and N-decanoyl chitosans: Binding affinity, cell uptake, and transfection.

  2012cited by this paper
• MicroRNA therapeutics

  2011cited by this paper
• Analytical aspects of microRNA in diagnostics: a review.

  2011cited by this paper
• Cationic Nanomicelles for Delivery of Plasmids Encoding Interleukin-4 and Interleukin-10 for Prevention of Autoimmune Diabetes in Mice

  2011cited by this paper
• Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.

  2011cited by this paper
• Revisit complexation between DNA and polyethylenimine--effect of length of free polycationic chains on gene transfection.

  2011cited by this paper
• Nanoparticle PEGylation for imaging and therapy.

  2011cited by this paper
• Multifunctional Triblock Nanocarrier (PAMAM-PEG-PLL) for the Efficient Intracellular siRNA Delivery and Gene Silencing

  2011cited by this paper
• Reduction-triggered delivery using nucleoside-lipid based carriers possessing a cleavable PEG coating.

  2011cited by this paper
• Dendrosome-dendriplex inside liposomes: as a gene delivery system

  2011cited by this paper
• Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers.

  2011cited by this paper
• A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA.

  2011cited by this paper
• Research progress on siRNA delivery with nonviral carriers

  2011cited by this paper
• Cationic polymer‐mediated small interfering RNA delivery for P‐glycoprotein down‐regulation in tumor cells

  2010cited by this paper
• Efficient gene transfection by histidine-modified chitosan through enhancement of endosomal escape.

  2010cited by this paper
• Biodegradable polymeric nanoparticles based drug delivery systems.

  2010cited by this paper
• Micromarkers: miRNAs in cancer diagnosis and prognosis

  2010cited by this paper
• Understanding biophysicochemical interactions at the nano-bio interface.

  2009cited by this paper
• Origins and Mechanisms of miRNAs and siRNAs.

  2009cited by this paper
• Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel.

  2009cited by this paper
• Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine.

  2009cited by this paper
• Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells

  2009cited by this paper
• Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers

  2009cited by this paper
• MicroRNAs — the micro steering wheel of tumour metastases

  2009cited by this paper
• Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.

  2009cited by this paper
• Relationship between the extent of lipid substitution on poly(L-lysine) and the DNA delivery efficiency.

  2009cited by this paper
• Dendrimers and their pharmaceutical applications--a review.

  2008cited by this paper
• Further investigation of lipid-substituted poly(L-Lysine) polymers for transfection of human skin fibroblasts.

  2008cited by this paper
• Immunological properties of engineered nanomaterials

  2007cited by this paper
• Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity.

  2007cited by this paper
• Repression of protein synthesis by miRNAs: how many mechanisms?

  2007cited by this paper
• High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation.

  2006cited by this paper
• Biophysical and Structural Characterization of Polyethylenimine-Mediated siRNA Delivery in Vitro

  2006cited by this paper
• Polymeric micelles for drug delivery.

  2006cited by this paper
• A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies.

  2006cited by this paper
• PEI-g-chitosan, a novel gene delivery system with transfection efficiency comparable to polyethylenimine in vitro and after liver administration in vivo.

  2006cited by this paper
• Dendrimers in gene delivery.

  2005cited by this paper
• Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis

  2005cited by this paper
• Perspective: machines for RNAi.

  2005cited by this paper
• Deoxycholic acid-conjugated chitosan oligosaccharide nanoparticles for efficient gene carrier.

  2005cited by this paper
• Dendrimers in drug research.

  2004cited by this paper

• Application of Nanomedicine in Tumor Targeting Inflammatory Pathway.

  2024cites this paper
• Unveiling the challenges of short non-coding RNAs and their prospects in cancer therapy

  2024cites this paper
• Antibody–Biopolymer Conjugates in Oncology: A Review

  2023cites this paper
• Research Status of Dendrimer Micelles in Tumor Therapy for Drug Delivery.

  2023cites this paper
• Genome-wide characterization of miRNA and siRNA pathways in the parasitoid wasp Pteromalus puparum

  2022cites this paper
• Natural and Synthetic Micelles for Delivery of Small Molecule Drugs, Imaging Agents and Nucleic Acids.

  2022cites this paper
• RNAi-based therapeutics and tumor targeted delivery in cancer.

  2022cites this paper
• Nanodiscs: a versatile nanocarrier platform for cancer diagnosis and treatment.

  2022cites this paper
• Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems.

  2021cites this paper
• Damage-Associated Molecular Patterns Modulation by microRNA: Relevance on Immunogenic Cell Death and Cancer Treatment Outcome

  2021cites this paper
• MicroRNA-429 acts as a tumor suppressor in colorectal cancer by targeting high mobility group box 3

  2021cites this paper
• Insight Into the Prospects for RNAi Therapy of Cancer

  2021cites this paper
• The role of artificial intelligence in scaling nanomedicine toward broad clinical impact

  2020cites this paper
• Nanotechnology approaches in the current therapy of skin cancer.

  2020cites this paper
• The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease

  2020cites this paper
• Stimuli-responsive and cellular targeted nanoplatforms for multimodal therapy of skin cancer.

  2020cites this paper
• Counterion of Chitosan Influences Thermodynamics of Association of siRNA with a Chitosan-Based siRNA Carrier

  2020cites this paper
• In vitro blood compatibility and in vitro cytotoxicity of amphiphilic poly-N-vinylpyrrolidone nanoparticles.

  2019cites this paper
• Effects of pericytes and colon cancer stem cells in the tumor microenvironment

  2019cites this paper
• miR-210-3p regulates the proliferation and apoptosis of non-small cell lung cancer cells by targeting SIN3A

  2019cites this paper
• Tuning the cationic interface of simple polydiacetylene micelles to improve siRNA delivery at the cellular level

  2019cites this paper
• MicroRNA delivery through nanoparticles

  2019cites this paper
• Improving the therapeutic efficiency of noncoding RNAs in cancers using targeted drug delivery systems.

  2019cites this paper
• tumor suppressor in colorectal cancer by targeting high mobility group box 3

  year unknowncites this paper